SMTL ID : 9hrc.1

Structure of MNK2 in complex with inhibitor NUCC-0201049

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 3.16 Å

Oligo State

monomer

Ligands

1 x ZN: ZINC ION(Non-covalent)

ZN.1: 4 residues within 4Å: Chain A: C.230, C.234, C.242, C.245 4 PLIP interactions: 4 interactions with chain A Metal complexes: A:C.230, A:C.234, A:C.242, A:C.245

1 x GOL: GLYCEROL(Non-functional Binders)

GOL.2: 6 residues within 4Å: Chain A: Q.68, G.69, H.70, V.73, E.75, K.154 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:Q.68, A:G.69, A:H.70, A:H.70, A:K.154

1 x 01: 1-[5-chloranyl-4-[(3~{R})-pyrrolidin-3-yl]oxy-pyrimidin-2-yl]benzimidazole

01.3: 16 residues within 4Å: Chain A: L.21, G.22, E.23, V.29, A.42, L.74, F.90, E.91, K.92, M.93, G.96, E.140, N.141, L.143, C.156, D.157 5 PLIP interactions: 5 interactions with chain A Hydrophobic interactions: A:L.21, A:L.21, A:L.143 Hydrogen bonds: A:M.93 Halogen bonds: A:D.157

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Vagadia, P.P. et al., Discovery of Potent and Selective MNK Kinase Inhibitors for the Treatment of Leukemia. J.Med.Chem. (2025)

Release Date

2025-03-12

Peptides

MAP kinase-interacting serine/threonine-protein kinase 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

MAP kinase-interacting serine/threonine-protein kinase 2

Related Entries With Identical Sequence